120 related articles for article (PubMed ID: 17935800)
1. Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases.
Li M; Maderdrut JL; Lertora JJ; Arimura A; Batuman V
Regul Pept; 2008 Jan; 145(1-3):24-32. PubMed ID: 17935800
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells.
Li M; Cortez S; Nakamachi T; Batuman V; Arimura A
Cancer Res; 2006 Sep; 66(17):8796-803. PubMed ID: 16951196
[TBL] [Abstract][Full Text] [Related]
3. Myeloma kidney: toward its prevention--with new insights from in vitro and in vivo models of renal injury.
Sengul S; Li M; Batuman V
J Nephrol; 2009; 22(1):17-28. PubMed ID: 19229815
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury.
Li M; Balamuthusamy S; Khan AM; Maderdrut JL; Simon EE; Batuman V
Peptides; 2010 Apr; 31(4):592-602. PubMed ID: 20034524
[TBL] [Abstract][Full Text] [Related]
5. Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury.
Arimura A; Li M; Batuman V
Blood; 2006 Jan; 107(2):661-8. PubMed ID: 16204306
[TBL] [Abstract][Full Text] [Related]
6. Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: a case study.
Li M; Maderdrut JL; Lertora JJ; Batuman V
Peptides; 2007 Sep; 28(9):1891-5. PubMed ID: 17582655
[TBL] [Abstract][Full Text] [Related]
7. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
El Zein N; Badran B; Sariban E
Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
[TBL] [Abstract][Full Text] [Related]
9. Renoprotection with pituitary adenylate cyclase-activating polypeptide in cyclosporine A-induced nephrotoxicity.
Khan AM; Li M; Brant E; Maderdrut JL; Majid DS; Simon EE; Batuman V
J Investig Med; 2011 Jun; 59(5):793-802. PubMed ID: 21383633
[TBL] [Abstract][Full Text] [Related]
10. The effects of pituitary adenylate cyclase activating polypeptide in renal ischemia/reperfusion.
László E; Kiss P; Horváth G; Szakály P; Tamás A; Reglődi D
Acta Biol Hung; 2014 Dec; 65(4):369-78. PubMed ID: 25475976
[TBL] [Abstract][Full Text] [Related]
11. Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38.
Arimura A; Li M; Batuman V
Ann N Y Acad Sci; 2006 Jul; 1070():1-4. PubMed ID: 16888145
[TBL] [Abstract][Full Text] [Related]
12. Effects of pituitary adenylate cyclase activating polypeptide on the survival and signal transduction pathways in human choriocarcinoma cells.
Boronkai A; Brubel R; Racz B; Tamas A; Kiss P; Horvath G; Lubics A; Szigeti A; Bellyei S; Toth G; Lakatos A; Reglodi D
Ann N Y Acad Sci; 2009 Apr; 1163():353-7. PubMed ID: 19456358
[TBL] [Abstract][Full Text] [Related]
13. Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-{kappa}B in chronic pancreatitis.
Michalski CW; Selvaggi F; Bartel M; Mitkus T; Gorbachevski A; Giese T; Sebastiano PD; Giese NA; Friess H
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G50-7. PubMed ID: 17962362
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive Intestinal Peptide and pituary adenylate cyclase-activating polypeptide inhibit tissue factor expression in monocyte in vitro and in vivo.
Lv B; Tang Y; Chen F; Xiao X
Shock; 2009 Feb; 31(2):185-91. PubMed ID: 18650785
[TBL] [Abstract][Full Text] [Related]
15. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
[TBL] [Abstract][Full Text] [Related]
16. Proximal tubular injury in myeloma.
Batuman V
Contrib Nephrol; 2007; 153():87-104. PubMed ID: 17075225
[TBL] [Abstract][Full Text] [Related]
17. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
[TBL] [Abstract][Full Text] [Related]
18. Grass carp somatolactin: II. Pharmacological study on postreceptor signaling mechanisms for PACAP-induced somatolactin-alpha and -beta gene expression.
Jiang Q; He M; Wang X; Wong AO
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E477-90. PubMed ID: 18523121
[TBL] [Abstract][Full Text] [Related]
19. Influence of pituitary adenylate cyclase-activating polypeptide on the activation of mitogen activated protein kinases following small bowel cold preservation.
Ferencz A; Reglo di D; Kalmár-Nagy K; Horváth OP; Ro Th E; Wéber G; Rácz B
Transplant Proc; 2009; 41(1):60-2. PubMed ID: 19249476
[TBL] [Abstract][Full Text] [Related]
20. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
Costa L; Santangelo F; Li Volsi G; Ciranna L
Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]